Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore
Background: The deployment of antimicrobial stewardship (AMS) teams to deal with the COVID-19 pandemic can lead to a loss of developed frameworks, best practices and leadership resulting in adverse impact on antimicrobial prescribing and resistance. We aim to investigate effects of reduction in AMS...
| Main Authors: | , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/146668 |
| _version_ | 1811689007602466816 |
|---|---|
| author | Ng, Tat Ming Tan, Sock Hoon Heng, Shi Thong Tay, Hui Lin Yap, Min Yi Chua, Boon Hou Teng, Christine B. Lye, David C. Lee, Tau Hong |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Ng, Tat Ming Tan, Sock Hoon Heng, Shi Thong Tay, Hui Lin Yap, Min Yi Chua, Boon Hou Teng, Christine B. Lye, David C. Lee, Tau Hong |
| author_sort | Ng, Tat Ming |
| collection | NTU |
| description | Background: The deployment of antimicrobial stewardship (AMS) teams to deal with the COVID-19 pandemic can lead to a loss of developed frameworks, best practices and leadership resulting in adverse impact on antimicrobial prescribing and resistance. We aim to investigate effects of reduction in AMS resources during the COVID-19 pan-demic on antimicrobial prescribing. Methods: One of 5 full-time equivalent AMS pharmacists was deployed to support pandemic work and AMS rounds with infectious disease physicians were reduced from 5 to 2 times a week. A survey in acute inpatients was con-ducted using the Global Point Prevalence Survey methodology in July 2020 and compared with those in 2015 and 2017–2019. Results: The prevalence of antimicrobial prescribing (55% in 2015 to 49% in 2019 and 47% in 2020, p = 0.02) and antibacterials (54% in 2015 to 45% in 2019 and 42% in 2020, p < 0.01) have been reducing despite the pandemic. Antimicrobial prescribing in infectious disease wards with suspected or confirmed COVID-19 cases was 29% in 2020. Overall, antimicrobial prescribing quality indicators continued to improve (e.g. reasons in notes, 91% in 2015 to 94% in 2019 and 97% in 2020, p < 0.01) or remained stable (compliance to guideline, 71% in 2015 to 62% in 2019 and 73% in 2020, p = 0.08). Conclusion: During the COVID-19 pandemic, there was no increase in antimicrobial prescribing and no significant differences in antimicrobial prescribing quality indicators. |
| first_indexed | 2024-10-01T05:41:15Z |
| format | Journal Article |
| id | ntu-10356/146668 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T05:41:15Z |
| publishDate | 2021 |
| record_format | dspace |
| spelling | ntu-10356/1466682023-03-05T16:50:31Z Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore Ng, Tat Ming Tan, Sock Hoon Heng, Shi Thong Tay, Hui Lin Yap, Min Yi Chua, Boon Hou Teng, Christine B. Lye, David C. Lee, Tau Hong Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine COVID-19 Antimicrobial Prevalence Background: The deployment of antimicrobial stewardship (AMS) teams to deal with the COVID-19 pandemic can lead to a loss of developed frameworks, best practices and leadership resulting in adverse impact on antimicrobial prescribing and resistance. We aim to investigate effects of reduction in AMS resources during the COVID-19 pan-demic on antimicrobial prescribing. Methods: One of 5 full-time equivalent AMS pharmacists was deployed to support pandemic work and AMS rounds with infectious disease physicians were reduced from 5 to 2 times a week. A survey in acute inpatients was con-ducted using the Global Point Prevalence Survey methodology in July 2020 and compared with those in 2015 and 2017–2019. Results: The prevalence of antimicrobial prescribing (55% in 2015 to 49% in 2019 and 47% in 2020, p = 0.02) and antibacterials (54% in 2015 to 45% in 2019 and 42% in 2020, p < 0.01) have been reducing despite the pandemic. Antimicrobial prescribing in infectious disease wards with suspected or confirmed COVID-19 cases was 29% in 2020. Overall, antimicrobial prescribing quality indicators continued to improve (e.g. reasons in notes, 91% in 2015 to 94% in 2019 and 97% in 2020, p < 0.01) or remained stable (compliance to guideline, 71% in 2015 to 62% in 2019 and 73% in 2020, p = 0.08). Conclusion: During the COVID-19 pandemic, there was no increase in antimicrobial prescribing and no significant differences in antimicrobial prescribing quality indicators. Published version 2021-03-04T07:36:19Z 2021-03-04T07:36:19Z 2021 Journal Article Ng, T. M., Tan, S. H., Heng, S. T., Tay, H. L., Yap, M. Y., Chua, B. H., . . . Lee, T. H. (2021). Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore. Antimicrobial Resistance and Infection Control, 10(1), 28-. doi:10.1186/s13756-021-00898-8 2047-2994 0000-0002-4570-3266 https://hdl.handle.net/10356/146668 10.1186/s13756-021-00898-8 33536077 2-s2.0-85100353516 1 10 en Antimicrobial Resistance and Infection Control © 2021 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. application/pdf |
| spellingShingle | Science::Medicine COVID-19 Antimicrobial Prevalence Ng, Tat Ming Tan, Sock Hoon Heng, Shi Thong Tay, Hui Lin Yap, Min Yi Chua, Boon Hou Teng, Christine B. Lye, David C. Lee, Tau Hong Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore |
| title | Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore |
| title_full | Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore |
| title_fullStr | Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore |
| title_full_unstemmed | Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore |
| title_short | Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore |
| title_sort | effects of coronavirus disease 2019 covid 19 pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in singapore |
| topic | Science::Medicine COVID-19 Antimicrobial Prevalence |
| url | https://hdl.handle.net/10356/146668 |
| work_keys_str_mv | AT ngtatming effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT tansockhoon effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT hengshithong effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT tayhuilin effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT yapminyi effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT chuaboonhou effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT tengchristineb effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT lyedavidc effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore AT leetauhong effectsofcoronavirusdisease2019covid19pandemiconantimicrobialprevalenceandprescribinginatertiaryhospitalinsingapore |